TrialNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2017

A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients.

Masafumi Fukagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.